WRBC
OACC

W.R. Berkley Corp’s Oaktree Acquisition Corp III Life Sciences OACC Stock Holding History

W.R. Berkley Corp’s Portfolio OACC Stock Details OACC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$2.37M Hold
223,645
– – 0.13% 161
2025
Q4 		$2.37M Hold
223,645
– – 0.11% 137
2025
Q3 		$2.35M Buy
223,645
+124,315
+125% +$1.3M 0.14% 131
2025
Q2 		$1.04M Hold
99,330
– – 0.05% 170
2025
Q1 		$1.02M Buy
+99,330
New +$997K 0.06% 127

Other funds holding OACC

AA
AQR Arbitrage Greenwich, Connecticut $6.09B AUM 27.01% 1-Year Est. Return
DAM
Decagon Asset Management London, United Kingdom $386M AUM 45.42% 1-Year Est. Return
FBCM
Fort Baker Capital Management Larkspur, California $1.27B AUM 25.46% 1-Year Est. Return
ECP
Empyrean Capital Partners Los Angeles, California $3.07B AUM 34.24% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
BGIM
Boussard & Gavaudan Investment Management London, United Kingdom $1.06B AUM 4.58% 1-Year Est. Return
LA
Linden Advisors New York $17.9B AUM 1.72% 1-Year Est. Return
SC
Sculptor Capital New York $9.61B AUM 27.49% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
MCM
Moore Capital Management New York $4.92B AUM 35.41% 1-Year Est. Return

W.R. Berkley Corp's OACC Position: Q1 2026 in Review

W.R. Berkley Corp held its Oaktree Acquisition Corp III Life Sciences (OACC) position steady in Q1 2026 at 223,645 shares worth $2.37M. The position accounts for 0.13% of the portfolio, ranked #161.

W.R. Berkley Corp first reported a position in OACC in Q1 2025 and has held it in 5 quarters since. 51 funds tracked by Wall St. Rank hold OACC as of Q1 2026.

  • W.R. Berkley Corp held 223,645 shares of Oaktree Acquisition Corp III Life Sciences worth $2.37M as of Q1 2026.
  • W.R. Berkley Corp left its Oaktree Acquisition Corp III Life Sciences share count unchanged in Q1 2026.
  • Oaktree Acquisition Corp III Life Sciences made up 0.13% of W.R. Berkley Corp's portfolio in Q1 2026, its #161 holding.
  • W.R. Berkley Corp first reported a position in Oaktree Acquisition Corp III Life Sciences in Q1 2025 and has held it in 5 quarters since.
  • 51 funds tracked by Wall St. Rank held Oaktree Acquisition Corp III Life Sciences as of Q1 2026.

Based on W.R. Berkley Corp's 13F filing for Q1 2026, filed 15 May 2026.